GSK GlaxoSmithKline PLC ADRs

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:GSK.

$43.99  -0.43 (-0.97%)
As of 05/27/2022 15:20:25 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  09/04/2001
Outstanding shares:  2,541,795,154
Average volume:  5,830,710
Market cap:   $114,304,528,075
Current dividend yield:  3.59%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      2374112

---

Valuation   (See tab for details)

---

PE ratio:   17.49
PB ratio:   6.90
PS ratio:   2.49
Return on equity:   31.60%
Net income %:   14.02%